2'-chloro-2'-deoxyadenosine has been researched along with 2-chloroadenosine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geisen, F; Grünewald, K; Konwalinka, G; Schirmer, M; Thaler, J; Umlauft, F; Vogel, W; Zilian, U | 1 |
Tefferi, A; Trendle, MC | 1 |
Delannoy, A | 1 |
Barbieri, D; Camaioni, E; Costanzi, S; Cristalli, G; Franceschi, C; Vittori, S; Volpini, R | 1 |
Champain, K; Csermak, K; Ganeshaguru, K; Gordon, M; Hart, SM; Hoffbrand, AV; Jones, DT; Man, A; Mehta, AB; Prentice, HG; Virchis, AE; Wickremasinghe, RG | 1 |
Arceci, RJ; Braier, J; Donadieu, J; Egeler, RM; Grois, N; Ladisch, S; Pötschger, U; Webb, D; Weitzman, S; Whitlock, J | 1 |
Blackburn, MR; Bruckner, BA; Bunge, RR; Garcia-Morales, LJ; Karmouty-Quintana, H; Loebe, M; Molina, JG; Pedroza, M; Seethamraju, H; Weng, T | 1 |
Bender, E; Bonaterra, GA; Hammerbacher, K; Kinscherf, R; Knies, C; Reuter, H; Rosemeyer, H | 1 |
1 review(s) available for 2'-chloro-2'-deoxyadenosine and 2-chloroadenosine
Article | Year |
---|---|
2-chloro-2'-deoxyadenosine: clinical applications in hematology.
Topics: 2-Chloroadenosine; Deoxyadenosines; Hematologic Diseases; Humans; Neoplasms; Treatment Outcome | 1996 |
1 trial(s) available for 2'-chloro-2'-deoxyadenosine and 2-chloroadenosine
Article | Year |
---|---|
2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Topics: 2-Chloroadenosine; Antimetabolites; Deoxyadenosines; Female; Histiocytes; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Prospective Studies; Risk; Salvage Therapy; Treatment Outcome | 2009 |
6 other study(ies) available for 2'-chloro-2'-deoxyadenosine and 2-chloroadenosine
Article | Year |
---|---|
Fulminant hepatitis C virus infection.
Topics: 2-Chloroadenosine; Alanine Transaminase; Clinical Enzyme Tests; Deoxyadenosines; Female; Hepatitis C; Humans; Leukemia, Hairy Cell; Middle Aged; Transfusion Reaction | 1994 |
Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
Topics: 2-Chloroadenosine; Deoxyadenosines; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Lysis Syndrome | 1994 |
Modulation of apoptosis in human lymphocytes by adenosine analogues.
Topics: 2-Chloroadenosine; Apoptosis; Cells, Cultured; Deoxyadenosines; Flow Cytometry; Humans; Lymphocytes; Models, Chemical; Propidium; Structure-Activity Relationship | 1998 |
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Calcium Channel Blockers; Chlorambucil; Deoxyadenosines; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; In Situ Nick-End Labeling; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Proteins; Palatine Tonsil; Protein Kinase C; Staurosporine; Tumor Cells, Cultured; Verapamil; Vidarabine | 2002 |
Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease.
Topics: 2-Chloroadenosine; Adenosine Deaminase; Animals; Apoptosis; Cells, Cultured; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine Kinase; Humans; Hypoxia; Mice; Pulmonary Disease, Chronic Obstructive; Up-Regulation | 2013 |
Synthesis of New Potential Lipophilic Co-Drugs of 2-Chloro-2'-deoxyadenosine (Cladribine, 2-CdA, Mavenclad®, Leustatin®) and 6-Azauridine (z
Topics: 2-Chloroadenosine; Animals; Antineoplastic Agents; Azauridine; Cell Proliferation; Cell Survival; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Rats; Structure-Activity Relationship; Tumor Cells, Cultured; Valproic Acid | 2019 |